{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:22:23Z","timestamp":1738041743961,"version":"3.33.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Children\u2019s Hospital at Montefiore","award":["The Children\u2019s Hospital at Montefiore"],"award-info":[{"award-number":["The Children\u2019s Hospital at Montefiore"]}]},{"name":"NIAMS IRP","award":["NIAMS IRP"],"award-info":[{"award-number":["NIAMS IRP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There are limited studies of juvenile dermatomyositis (JDM) in low and middle-income countries (LMIC). Many demonstrate delays to care, high prevalence of severe manifestations, and high mortality. Given the disease-associated damage with JDM, understanding JDM in Africa further is critical. Our objectives are to understand the burden of JDM in Africa and provider access to diagnostic tools and therapy through survey methodology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A survey (available in English and French) was distributed via WhatsApp to 363 total members of the African League of Associations for Rheumatology (AFLAR; <jats:italic>n<\/jats:italic>\u2009=\u2009233) and Paediatric Society of the African League Against Rheumatism (PAFLAR; <jats:italic>n<\/jats:italic>\u2009=\u2009130) from November 2022-January 2023. Topics included respondent specialty, number of JDM patients followed, severe manifestations, and available diagnostic tools and medications (with and without considering cost).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty-three (12%) of the 363 providers who received the survey started it. Among the 43 who started the survey, 37 (86%) provided consent and manage JDM patients; of these 37 providers, 4 (11%) partially and 16 (43%) fully completed the survey. Most were adult and\/or pediatric rheumatologists (<jats:italic>n<\/jats:italic>\u2009=\u200919; 95%). Respondents represented all 5 African regions and described 216 children with JDM within the last 10 years. There was high prevalence of calcinosis (as high as 100%) and interstitial lung disease (ILD) (as high as 32%); mortality rates in Kenya (6\/42; 14%) and Zambia (2\/7; 29%) exceeded the 1\u20133% mortality reported in studies of high-income countries. Thirteen of 27 diagnostic tools and medications were accessible to \u2264\u200950% of respondents after considering cost, mostly in Northern or Southern Africa (9\/13; 69%). Despite being cost-free, disease assessment tools and physical exam to assess calcinosis were not reported as universally available or accessible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first study to explore experiences of providers caring for children with JDM in Africa. Respondents identified 216 children with JDM seen within the last 10 years, exceeding the 196 children with JDM reported within the last 25 years but likely still underestimating prevalence. Our findings align with reports of severe manifestations and poor outcomes in African children with JDM. Access to many diagnostics and medications is limited, and differences in accessibility parallel regional healthcare disparities. The potential differences in JDM severity warrant systematic study and highlight the need to include patients and providers from LMIC in collaborative research efforts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12969-024-01009-8","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:34:12Z","timestamp":1737963252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-7348","authenticated-orcid":false,"given":"Jessica","family":"Perfetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura B.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn M.","family":"Wahezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Ogega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Ahimbisibwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Migowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"1","key":"1009_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.rdc.2021.09.001","volume":"48","author":"C Scott","year":"2022","unstructured":"Scott C, Sawhney S, Lewandowski LB. Pediatric Rheumatic Disease in Lower to Middle-Income countries: impact of global disparities, ancestral diversity, and the path Forward. Rheum Dis Clin North Am. 2022;48(1):199\u2013215.","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"1009_CR2","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s10067-014-2747-3","volume":"33","author":"S Singh","year":"2014","unstructured":"Singh S, Suri D, Aulakh R, Gupta A, Rawat A, Kumar RM. Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India. Clin Rheumatol. 2014;33(11):1675\u20139.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"1009_CR3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00296-017-3770-x","volume":"37","author":"SM Al-Mayouf","year":"2017","unstructured":"Al-Mayouf SM, AlMutiari N, Muzaffer M, Shehata R, Al-Wahadneh A, Abdwani R, et al. Phenotypic characteristics and outcome of juvenile dermatomyositis in arab children. Rheumatol Int. 2017;37(9):1513\u20137.","journal-title":"Rheumatol Int"},{"issue":"1","key":"1009_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-020-0418-2","volume":"18","author":"FF Furia","year":"2020","unstructured":"Furia FF, Godfrey E, Mwamanenge N, Swai P. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania. Pediatr Rheumatol Online J. 2020;18(1):30.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"1009_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12969-017-0139-3","volume":"15","author":"BH Olaosebikan","year":"2017","unstructured":"Olaosebikan BH, Adelowo OO, Animashaun BA, Akintayo RO. Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J. 2017;15(1):7.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1009_CR6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/1756-185X.12053","volume":"16","author":"S Prasad","year":"2013","unstructured":"Prasad S, Misra R, Agarwal V, Lawrence A, Aggarwal A. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade? Int J Rheum Dis. 2013;16(5):556\u201360.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1009_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"N Martin","year":"2011","unstructured":"Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years\u2019 experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for idiopathic inflammatory myopathies. Rheumatology (Oxford). 2011;50(1):137\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1009_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/acr.22142","volume":"66","author":"AB Robinson","year":"2014","unstructured":"Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, et al. Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res (Hoboken). 2014;66(3):404\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1009_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s11926-005-0048-1","volume":"7","author":"A Huber","year":"2005","unstructured":"Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep. 2005;7(6):441\u20136.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1009_CR10","first-page":"117","volume":"29","author":"D Guseinova","year":"2011","unstructured":"Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N, et al. Comparison of clinical features and drug therapies among European and latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol. 2011;29(1):117\u201324.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"1009_CR11","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","volume":"48","author":"H Sanner","year":"2009","unstructured":"Sanner H, Gran JT, Sjaastad I, Flat\u00f8 B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford). 2009;48(12):1541\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1009_CR12","first-page":"782","volume":"28","author":"PR Mathiesen","year":"2010","unstructured":"Mathiesen PR, Zak M, Herlin T, Nielsen SM. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol. 2010;28(5):782\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"1009_CR13","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","volume":"60","author":"LG Rider","year":"2009","unstructured":"Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum. 2009;60(11):3425\u201335.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1009_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s13312-013-0260-4","volume":"50","author":"PR Chickermane","year":"2013","unstructured":"Chickermane PR, Mankad D, Khubchandani RP. Disease patterns of juvenile dermatomyositis from Western India. Indian Pediatr. 2013;50(10):961\u20133.","journal-title":"Indian Pediatr"},{"issue":"10","key":"1009_CR15","first-page":"931","volume":"39","author":"V Chowdhary","year":"2002","unstructured":"Chowdhary V, Wakhlu A, Agarwal A, Misra R. Outcome in juvenile dermatomyositis. Indian Pediatr. 2002;39(10):931\u20135.","journal-title":"Indian Pediatr"},{"issue":"1","key":"1009_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken). 2010;62(1):63\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1009_CR17","first-page":"1031","volume":"27","author":"JO Sato","year":"2009","unstructured":"Sato JO, Sallum AM, Ferriani VP, Marini R, Sacchetti SB, Okuda EM, et al. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin Exp Rheumatol. 2009;27(6):1031\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1009_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","volume":"84","author":"AM Sallum","year":"2008","unstructured":"Sallum AM, Pivato FC, Doria-Filho U, Aikawa NE, Liphaus BL, Marie SK, et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr (Rio J). 2008;84(1):68\u201374.","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s13256-021-03222-5","volume":"15","author":"F Mussa","year":"2021","unstructured":"Mussa F, Nalitolela N, Fredrick F. An 8-year-old-girl with juvenile dermatomyositis and autoimmune thyroiditis in Tanzania: a case report. J Med Case Rep. 2021;15(1):632.","journal-title":"J Med Case Rep"},{"issue":"2","key":"1009_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ccr3.816","volume":"5","author":"ML Grijsen","year":"2017","unstructured":"Grijsen ML, McHaile D, Geut I, Olomi R, Nwako M, Requena L, et al. Juvenile dermatomyositis in a 4-year-old Kenyan girl. Clin Case Rep. 2017;5(2):134\u20138.","journal-title":"Clin Case Rep"},{"key":"1009_CR21","doi-asserted-by":"crossref","unstructured":"Adelowo O, Nwankwo M, Olaosebikan H. Juvenile dermatomyositis in a Nigerian girl. BMJ Case Rep. 2014;2014.","DOI":"10.1136\/bcr-2013-202132"},{"issue":"1","key":"1009_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.22551\/2020.26.0701.10165","volume":"7","author":"R Aliu","year":"2020","unstructured":"Aliu R, Aliyu LI, Obiagwu PN, Olatoke L, Ebisike JK. Juvenile dermatomyositis in a 14-year old Nigerian girl. Arch Clin Cases. 2020;7(1):5\u20139.","journal-title":"Arch Clin Cases"},{"issue":"4","key":"1009_CR23","first-page":"458","volume":"23","author":"CE Mandengue","year":"2013","unstructured":"Mandengue CE, Nouedoui C, Atangana PJ. [Unrecognized juvenile dermatomyositis complicated by calcinosis universalis: a case report from Cameroon]. Med Sante Trop. 2013;23(4):458\u201361.","journal-title":"Med Sante Trop"},{"issue":"4","key":"1009_CR24","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10067-020-05048-w","volume":"40","author":"KJ Chinniah","year":"2021","unstructured":"Chinniah KJ, Mody GM. The spectrum of idiopathic inflammatory myopathies in South Africa. Clin Rheumatol. 2021;40(4):1437\u201346.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1009_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12969-016-0118-0","volume":"14","author":"LO Okong\u2019o","year":"2016","unstructured":"Okong\u2019o LO, Esser M, Wilmshurst J, Scott C. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Pediatr Rheumatol Online J. 2016;14(1):60.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1009_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1546-0096-12-2","volume":"12","author":"G Faller","year":"2014","unstructured":"Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"1009_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.55563\/clinexprheumatol\/h0s7tq","volume":"40","author":"K El-Garf","year":"2022","unstructured":"El-Garf K, El-Garf A, Salah S, Marzouk H, Farag Y, Mostafa N. A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort. Clin Exp Rheumatol. 2022;40(2):450\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1009_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpeds.2017.01.046","volume":"184","author":"K Phillippi","year":"2017","unstructured":"Phillippi K, Hoeltzel M, Byun Robinson A, Kim S. Race, income, and Disease outcomes in Juvenile Dermatomyositis. J Pediatr. 2017;184:38\u2013e441.","journal-title":"J Pediatr"},{"issue":"4","key":"1009_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.berh.2017.12.003","volume":"31","author":"Q Wu","year":"2017","unstructured":"Wu Q, Wedderburn LR, McCann LJ. Juvenile dermatomyositis: latest advances. Best Pract Res Clin Rheumatol. 2017;31(4):535\u201357.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1009_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.rdc.2021.07.003","volume":"47","author":"H Kim","year":"2021","unstructured":"Kim H, Huber AM, Kim S. Updates on Juvenile Dermatomyositis from the last decade: classification to outcomes. Rheum Dis Clin North Am. 2021;47(4):669\u201390.","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 1","key":"1009_CR31","doi-asserted-by":"publisher","first-page":"P218","DOI":"10.1186\/1546-0096-6-S1-P218","volume":"6","author":"S Smith","year":"2008","unstructured":"Smith S, Juggins A, Evans S, Pilkington C. What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era. Pediatr Rheumatol Online J. 2008;6(Suppl 1):P218\u2013P.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1009_CR32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/BOR.0b013e3283635634","volume":"25","author":"A Huber","year":"2013","unstructured":"Huber A, Feldman BM. An update on inflammatory myositis in children. Curr Opin Rheumatol. 2013;25(5):630\u20135.","journal-title":"Curr Opin Rheumatol"},{"key":"1009_CR33","first-page":"101","volume":"64","author":"S Bitnum","year":"1964","unstructured":"Bitnum S, Daeschner CW Jr., Travis LB, Dodge WF, Hopps HC. DERMATOMYOSITIS J Pediatr. 1964;64:101\u201331.","journal-title":"DERMATOMYOSITIS J Pediatr"},{"issue":"9","key":"1009_CR34","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/art.21291","volume":"52","author":"CV Oddis","year":"2005","unstructured":"Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 2005;52(9):2607\u201315.","journal-title":"Arthritis Rheum"},{"key":"1009_CR35","unstructured":"Official and Spoken Languages of African Countries. [ https:\/\/www.nationsonline.org\/oneworld\/african_languages.htm"},{"issue":"1","key":"1009_CR36","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1186\/s12913-023-10366-1","volume":"23","author":"KS Oluwadiya","year":"2023","unstructured":"Oluwadiya KS, Olasinde AA, Adeoti AO, Adeoye O, Oluwadiya IO, Kadiri IA. The high cost of healing and teaching: a cross-sectional survey of burnout among academic physicians in Nigeria. BMC Health Serv Res. 2023;23(1):1357.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"1009_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/heapol\/czab024","volume":"36","author":"K Manji","year":"2021","unstructured":"Manji K, Hanefeld J, Vearey J, Walls H, de Gruchy T. Using WhatsApp messenger for health systems research: a scoping review of available literature. Health Policy Plan. 2021;36(5):594\u2013605.","journal-title":"Health Policy Plan"},{"issue":"1","key":"1009_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/09540121.2021.1883506","volume":"34","author":"EI Sianturi","year":"2022","unstructured":"Sianturi EI, Latifah E, Pane M, Perwitasari DA, Satibi, Kristina SA, et al. Knowledge, empathy, and willingness to counsel patients with HIV among Indonesian pharmacists: a national survey of stigma. AIDS Care. 2022;34(1):21\u20138.","journal-title":"AIDS Care"},{"issue":"1","key":"1009_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12969-021-00557-7","volume":"19","author":"AN Migowa","year":"2021","unstructured":"Migowa AN, Hadef D, Hamdi W, Mwizerwa O, Ngandeu M, Taha Y, et al. Pediatric rheumatology in Africa: thriving amidst challenges. Pediatr Rheumatol Online J. 2021;19(1):69.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"1009_CR40","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/bjd.18799","volume":"182","author":"C Moegle","year":"2020","unstructured":"Moegle C, Severac F, Lipsker D. Epidemiology of juvenile dermatomyositis in Alsace. Br J Dermatol. 2020;182(5):1307\u20138.","journal-title":"Br J Dermatol"},{"key":"1009_CR41","unstructured":"United Nations DoEaSA, Population Division. World Population Prospects 2022 2023 [updated 2022. https:\/\/population.un.org\/wpp\/"},{"issue":"1","key":"1009_CR42","doi-asserted-by":"publisher","first-page":"A65","DOI":"10.1186\/1546-0096-10-S1-A65","volume":"10","author":"MF Hoeltzel","year":"2012","unstructured":"Hoeltzel MF, Becker ML, Robinson AB, Feldman BM, Huber A, Reed AM, et al. Race is a risk factor for calcinosis in patients with JDM \u2013 early results from the CARRAnet registry study. Pediatr Rheumatol. 2012;10(1):A65.","journal-title":"Pediatr Rheumatol"},{"issue":"10","key":"1009_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"LJ McCann","year":"2006","unstructured":"McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 year. Rheumatology (Oxford). 2006;45(10):1255\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1009_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/ard.2010.131433","volume":"70","author":"H Sanner","year":"2011","unstructured":"Sanner H, Aal\u00f8kken TM, Gran JT, Sjaastad I, Johansen B, Flat\u00f8 B. Pulmonary outcome in juvenile dermatomyositis: a case-control study. Ann Rheum Dis. 2011;70(1):86\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1009_CR45","unstructured":"Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990\u20132015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017;390(10091):231\u2009\u2013\u200966."},{"issue":"2","key":"1009_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76(2):329\u201340.","journal-title":"Ann Rheum Dis"},{"key":"1009_CR47","doi-asserted-by":"publisher","unstructured":"Migowa ANHW, Hashad S et al. The Clinical-Epidemiological Profile of Juvenile Idiopathic Arthritis in Africa: data from the Paediatric Society of the African League against Rheumatism (PAFLAR) Registry. PREPRINT (Version 1) available at Research Square [https:\/\/doi.org\/10.21203\/rs3rs-3918846\/v1]. 2024.","DOI":"10.21203\/rs3rs-3918846\/v1"},{"issue":"1","key":"1009_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12969-023-00790-2","volume":"21","author":"A Migowa","year":"2023","unstructured":"Migowa A, Bernatsky S, Ngugi A, Foster HE, Muriuki P, Lusambili A, et al. An iceberg I can\u2019t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya. Pediatr Rheumatol. 2023;21(1):6.","journal-title":"Pediatr Rheumatol"},{"issue":"1","key":"1009_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12969-022-00752-0","volume":"20","author":"W Slamang","year":"2022","unstructured":"Slamang W, Smith N, Scott C, Foster H. Revising the WHO essential Medicines list for paediatric rheumatology update. Pediatr Rheumatol Online J. 2022;20(1):89.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"1009_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41584-020-0368-6","volume":"16","author":"HE Foster","year":"2020","unstructured":"Foster HE, Scott C. Update the WHO EML to improve global paediatric rheumatology. Nat Rev Rheumatol. 2020;16(3):123.","journal-title":"Nat Rev Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-024-01009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-024-01009-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-024-01009-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T08:22:34Z","timestamp":1737966154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-024-01009-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1186\/s12969-024-01009-8","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Albert Einstein College of Medicine Institutional Review Board (IRB) approval was obtained (approval number 2022\u201313864) with waiver of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have non-competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}